Canada authorizes Mo-99 production at Darlington station

November 12, 2021, 9:30AMNuclear News
Darlington nuclear power plant. (Photo: OPG)

The Canadian Nuclear Safety Commission (CNSC) has amended Ontario Power Generation’s (OPG) operating license for its Darlington nuclear power station near Clarington, Ontario, allowing the company to produce the medical radioisotope molybdenum-99 using Darlington’s Unit 2 CANDU reactor. OPG subsidiary Laurentis Energy Partners, in conjunction with BWXT Medical, is leading the program to produce Mo-99 at Darlington.

To continue reading, log in or create a free account!

Related Articles

Saskatchewan expands its nuclear plans

January 30, 2026, 12:21PMNuclear News

This week, the government of Saskatchewan, alongside electric utility SaskPower, announced plans to formally evaluate the deployment of large nuclear technologies. This process will take place...